Drugs that contain Rifamycin Sodium

1. List of Aemcolo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8486446 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

US8741948 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

US8263120 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

US8529945 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(2 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Nov 16, 2023
Generating Antibiotic Incentives Now (GAIN) Nov 16, 2028

NCE-1 date: 2027-11-17

Market Authorisation Date: 16 November, 2018

Treatment: Treatment of travelers' diarrhea caused by non-invasive strains of escherichia coli in adults

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

AEMCOLO family patents

10

United States

3

European Union

2

Korea, Republic of

2

China

2

Japan

2

Canada

1

South Africa

1

Denmark

1

Austria

1

Mexico

1

Slovenia

1

Hungary

1

Germany

1

Croatia

1

Portugal

1

Cyprus

1

Spain

1

Italy

1

Poland

1

RS

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in